Megalis
Megalis

0.62
Used to address erectile dysfunction, this generic medicine supports blood flow to the reproductive organs by relaxing smooth muscle tissues in the arterial walls.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tadalafil
Reference Brand
Tadalafil
Product Origin
Generic Brand
Product Manufacturer
Macleods Pharmaceuticals Ltd
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Erectile Dysfunction
Product Category
Phosphodiesterase-5 Inhibitor
Pharmacological Class
PDE5 Inhibitor
Clinical Indications
Manufacturer Description
Designed to support long-term erectile capability to manage performance concerns and alleviate pelvic vascular tension.
Mechanism of Action
Inhibits phosphodiesterase-5 to preserve localized cGMP, relaxing pelvic arterial walls to promote structural blood filling.
Route of Administration
Oral
Onset Time
30–45 minutes
Duration
36 hours
Contraindications
Organic nitrates, Severe hepatic or renal impairment
Severe Adverse Events
Priapism — requires immediate medical attention
Common Side Effects
Headache, Dyspepsia, Myalgia
Uncommon Side Effects
Nasal congestion, Back pain, Flushing
Drug Interactions
Nitrates, Alpha Blockers, Ketoconazole
Pregnancy Safety Warnings
TGA Category B: Not indicated for females. Breastfeeding: Not applicable.
Age Restrictions
Approved for adult men.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Megalis is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to buy Cancer Treatment Tablets - Letrozole Aromatase Inhibitor Breast Cancer